Silvia Delgado Villalta

CMS Newborn Screening - COQHX

109 Cystic Fibrosis Foundation Care Center and Patient Registry

109 Cystic Fibrosis Foundation Care Center and Patient Registry.

Therapeutics Development Center Award 2024-2025

109 Cystic Fibrosis Foundation Care Center and Patient Registry.

109 Cystic Fibrosis Foundation Care Center and Patient Registry.

Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes

CTOA

Therapeutics Development Center Award

Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults with Cystic Fibrosis

CF Outpatient Physical Therapist Support

109 Cystic Fibrosis Foundation Care Center and Patient Registry.

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

109 Cystic Fibrosis Foundation Care Center and Patient Registry

A master protocol to test the impact of discontinuing chronic therapies in people with cystic fibrosis on highly effective CFTR modulator therapy (SIMPLIFY)

109 Cystic Fibrosis Foundation Care Center and Patient Registry

Therapeutics Development Center

109 Cystic Fibrosis Foundation Care Center and Patient Registry

First Year Clinical Fellowship

Implementation of Outpatient Clinical Pharmacy Services: Award for A Pharmacist and/or Pharmacy Technician

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AeroVanc for the Treatment of Persistent Methicillin-Resistant Stphylococcus Aureus Lung Infection in Cystic Fibrosis Patients

Fundamentals Learning and Leadership Collaborative 3

Telemedicine Genetic Counseling in the Provision of CF Newborn Screening

Implementation of Outpatient Clinical Pharmacy Services

Psychometric Evaluation of the Gastrointestinal (GI) Symptom Tracker in Patients With Cystic Fibrosis